Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Vikor Scientific | UNKNOWN |
| Thermo Fisher Scientific, Inc | INDUSTRY |
Not provided
Not provided
Not provided
The objective of this study is the detection, quantification, and resistance gene identification of pathogens by using the urine of patients with urinary tract infection (UTI) symptoms.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients over 60 years old presenting with acute urinary tract infection symptoms |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Urine PCR testing | Diagnostic Test | The urine PCR panel will be performed to evaluate the bacterial growth in the patient's urine who is admitted with acute urinary tract symptoms. |
| Measure | Description | Time Frame |
|---|---|---|
| Time in hours from patient presentation to optimal antibiotic prescription | Time in hours from patient presentation to optimal antibiotic prescription will be evaluated both for urine culture and urine PCR panel utilization. | Up to 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Antibiotic costs as measured by prescription records | Antibiotic costs spent for UTI treatment will be calculated. | Up to 30 days |
| Number of patients with antibiotic change as measured by prescription records |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Female and male patients over 60 years old who admit with acute urinary tract infection symptoms to the ambulatory clinics will be included in this research.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Sheyn, MD | University Hospitals Cleveland Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals | Cleveland | Ohio | 44106 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40911199 | Derived | Bauer HH, Jarvis MA, Hoffberg EA, Batur AF, Hojat LS, Hijaz AK, Sheyn D. Multiplex Polymerase Chain Reaction vs Standard Urine Culture in Women Presenting with Symptoms of Acute Cystitis. Int Urogynecol J. 2025 Dec;36(12):2517-2526. doi: 10.1007/s00192-025-06295-8. Epub 2025 Sep 5. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014552 | Urinary Tract Infections |
| ID | Term |
|---|---|
| D007239 | Infections |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
In cases where the UTI cannot be treated with the first antibiotic, other antibiotics used for this purpose will be recorded.
| Up to 30 days |
| Duration of antibiotic usage as measured by prescription records | Antibiotic usage duration will be recorded. | Up to 30 days |
| Number of any HCP visits for same issue as measured by patients reports/medical records | Any visit to HCP for the same issue will be evaluated | Up to 30 days |
| Number of hospitalization related to UTI as measured by patients reports/medical records | Hospitalization related to UTI will be recorded. | Up to 30 days |
| Number of additional diagnostic procedures completed in relation to UTI as measured by patients reports/medical records | Additional diagnostic procedures completed in relation to UTI will be recorded. | Up to 30 days |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |